✦ LIBER ✦

P.3.006 A double-blind, placebo-controlled trial ofvenlafaxine XR in the short-term treatment of panic disorder

✍ Scribed by M.R. Liebowitz; G. Asnis; E. Tzanis; T. Whitaker

Book ID: 118590744
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 232 KB
Volume: 14
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(04)80386-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.3.013 Pindoiol augmentation in the tre

P.3.013 Pindoiol augmentation in the treatment of resistant panic disorder: A double-blind placebo-controlled trial

✍ Pinhas N. Dannon; Shmuel Hirschmann; Seth Kindler; Tulian Iancu; Ornah T. Dolber 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 144 KB

P.3.058 Venlafaxine XR and paroxetine in

P.3.058 Venlafaxine XR and paroxetine in the short-term treatment of panic disorder

✍ U. Lepola; M. Pollack; G. Emilien; E. Tzanis; T. Whitaker 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Cyproheptadine in the treatment of autis

Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial

✍ S. Akhondzadeh; S. Erfani; M. R. Mohammadi; M. Tehrani-Doost; H. Amini; S. S. Gu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Fluvoxamine in the treatment of panic di

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

✍ Gregory M Asnis; Faiq A Hameedi; Andrew W Goddard; Steven G Potkin; Donald Black 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 135 KB

Alprazolam in the treatment of generaliz

Alprazolam in the treatment of generalized anxiety and panic disorders: A double-blind placebo-controlled study

✍ G. Chouinard; L. Annable; R. Fontaine; L. Solyom 📂 Article 📅 1982 🏛 Springer 🌐 English ⚖ 472 KB

In a double-blind controlled study lasting 8 weeks, 50 anxious psychoneurotic outpatients with a primary diagnosis of generalized anxiety or panic disorder were randomly assigned to alprazolam (n = 30), a new benzodiazepine, or placebo (n = 20), after a washout period of 1 week. Alprazolam at dosage

P.2.109 A double-blind placebo-controlle

P.2.109 A double-blind placebo-controlled trial of risperidone in autistic disorder

✍ C.J. McDougle; M.G. Aman; J.T. McCracken; L. Scahill; E. Tierney; B. Vitiello 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 272 KB